ECO Animal Health Group Stock Price Target and Analyst Ratings (LON:EAH)

Analyst Price Target for EAH

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

GBX 0

▼ -100.00% Downside Potential

This price target is based on 1 analysts offering 12 month price targets for ECO Animal Health Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 338.

Buy

The current consensus among 1 contributing investment analysts is to buy stock in ECO Animal Health Group. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

9/10/2019

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/9/2019

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/8/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/6/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

9/4/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/3/2020

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

2/1/2021

0 strong buy ratings
1 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/3/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Details
7/2/2020	Peel Hunt	Reiterated Rating	Buy		i
6/10/2020	Peel Hunt	Reiterated Rating	Buy		i
6/3/2020	Peel Hunt	Reiterated Rating	Buy		i
5/25/2020	Peel Hunt	Reiterated Rating	Buy		i
5/8/2020	Peel Hunt	Reiterated Rating	Buy		i
5/1/2020	Peel Hunt	Reiterated Rating	Buy		i
4/7/2020	Peel Hunt	Reiterated Rating	Buy		i
3/5/2020	Peel Hunt	Reiterated Rating	Buy		i
2/19/2020	Peel Hunt	Lower Price Target	Buy	GBX 460 ➝ GBX 430	i
2/13/2020	Peel Hunt	Reiterated Rating	Buy		i
2/5/2020	Peel Hunt	Reiterated Rating	Buy		i
1/30/2020	Peel Hunt	Reiterated Rating	Buy		i
1/10/2020	Peel Hunt	Reiterated Rating	Buy		i
12/31/2019	Peel Hunt	Reiterated Rating	Buy		i
12/11/2019	Peel Hunt	Reiterated Rating	Buy		i
12/5/2019	Peel Hunt	Reiterated Rating	Buy		i
11/11/2019	Peel Hunt	Lower Price Target	Buy	GBX 600 ➝ GBX 460	i
11/4/2019	Peel Hunt	Reiterated Rating	Buy		i
10/7/2019	Peel Hunt	Reiterated Rating	Buy		i
9/11/2019	Peel Hunt	Reiterated Rating	Buy		i
9/2/2019	Peel Hunt	Reiterated Rating	Buy		i
8/19/2019	Peel Hunt	Reiterated Rating	Buy		i
8/1/2019	Peel Hunt	Reiterated Rating	Buy		i
7/3/2019	Peel Hunt	Reiterated Rating	Buy		i
6/19/2019	Peel Hunt	Lower Price Target	Buy	GBX 725 ➝ GBX 600	i
6/10/2019	Peel Hunt	Reiterated Rating	Buy		i
6/3/2019	Peel Hunt	Reiterated Rating	Buy		i
5/27/2019	Peel Hunt	Reiterated Rating	Buy		i
5/2/2019	Peel Hunt	Reiterated Rating	Buy		i
4/8/2019	Peel Hunt	Reiterated Rating	Buy		i
4/2/2019	Peel Hunt	Reiterated Rating	Buy		i
3/5/2019	Peel Hunt	Reiterated Rating	Buy		i
2/13/2019	Peel Hunt	Reiterated Rating	Buy		i
2/1/2019	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
1/3/2019	Peel Hunt	Reiterated Rating	Buy		i
12/6/2018	Peel Hunt	Reiterated Rating	Buy		i
11/19/2018	Peel Hunt	Reiterated Rating	Buy		i
11/7/2018	Peel Hunt	Reiterated Rating	Buy		i
11/1/2018	Peel Hunt	Reiterated Rating	Buy		i
10/12/2018	Peel Hunt	Reiterated Rating	Buy		i
10/3/2018	Peel Hunt	Reiterated Rating	Buy		i
9/4/2018	Peel Hunt	Reiterated Rating	Buy		i
8/28/2018	Peel Hunt	Reiterated Rating	Buy		i
8/1/2018	Peel Hunt	Reiterated Rating	Buy		i
7/2/2018	Liberum Capital	Reiterated Rating	Buy	GBX 725	i
7/2/2018	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
5/30/2018	Peel Hunt	Reiterated Rating	Buy		i
4/3/2018	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
2/1/2018	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
12/19/2017	N+1 Singer	Reiterated Rating	Corporate		i
12/19/2017	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
12/6/2017	N+1 Singer	Reiterated Rating	Corporate		i
12/6/2017	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
8/21/2017	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
8/14/2017	N+1 Singer	Reiterated Rating	corporate		i
7/24/2017	Peel Hunt	Reiterated Rating	Buy	GBX 725	i
6/30/2017	Peel Hunt	Boost Price Target	Buy	GBX 650 ➝ GBX 725	i
6/5/2017	Peel Hunt	Reiterated Rating	Buy	GBX 660	i
5/15/2017	Peel Hunt	Boost Price Target	Buy	GBX 575 ➝ GBX 650	i
1/9/2017	N+1 Singer	Reiterated Rating	Corporate		i
1/5/2017	Peel Hunt	Reiterated Rating	Buy	GBX 575	i
12/12/2016	Peel Hunt	Boost Price Target	Buy	GBX 550 ➝ GBX 575	i
12/12/2016	N+1 Singer	Reiterated Rating	Corporate		i
12/5/2016	N+1 Singer	Reiterated Rating	Corporate		i
12/5/2016	Peel Hunt	Reiterated Rating	Buy	GBX 550	i
10/19/2016	N+1 Singer	Reiterated Rating	Buy	GBX 498	i
9/19/2016	Peel Hunt	Boost Price Target	Buy	GBX 450 ➝ GBX 550	i
9/16/2016	N+1 Singer	Reiterated Rating	Buy	GBX 498	i
7/1/2016	Peel Hunt	Boost Price Target	Buy	GBX 375 ➝ GBX 450	i
6/6/2016	Peel Hunt	Reiterated Rating	Buy	GBX 375	i
4/22/2016	Peel Hunt	Reiterated Rating	Buy	GBX 375	i
4/14/2016	Peel Hunt	Reiterated Rating	Buy	GBX 375	i
3/31/2016	Peel Hunt	Boost Price Target	Buy	GBX 350 ➝ GBX 375	i

(Data available from 3/4/2016 forward)

ECO Animal Health Group plc develops and markets pharmaceutical products for animals worldwide. The company offers Aivlosin, a macrolide antibiotic for the treatment of respiratory and enteric diseases in pigs and poultry. It also provides generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. The company was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Today's Range

Now: GBX 338

331

339

50 Day Range

MA: GBX 293.40

247.50

345

52 Week Range

Now: GBX 338

110

350

Volume

46,230 shs

Average Volume

325,288 shs

Market Capitalization

£228.31 million

P/E Ratio

67.60

Dividend Yield

7.34%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ECO Animal Health Group?

The following sell-side analysts have issued reports on ECO Animal Health Group in the last year: Peel Hunt.
View the latest analyst ratings for EAH.

What is the current price target for ECO Animal Health Group?

0 Wall Street analysts have set twelve-month price targets for ECO Animal Health Group in the last year. has the lowest price target set, forecasting a price of £100,000 for ECO Animal Health Group in the next year.
View the latest price targets for EAH.

What is the current consensus analyst rating for ECO Animal Health Group?

ECO Animal Health Group currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe EAH will outperform the market and that investors should add to their positions of ECO Animal Health Group.
View the latest ratings for EAH.

What other companies compete with ECO Animal Health Group?

Other companies that are similar to ECO Animal Health Group include Vectura Group plc (VEC.L), Beximco Pharmaceuticals, Allergy Therapeutics plc (AGY.L), Trilogy International Partners, Sareum Holdings plc (SAR.L), Futura Medical, Avivagen, N4 Pharma, Cathay International Holdings Limited (CTI.L), Antisense Therapeutics, Bayer Aktiengesellschaft, Mayne Pharma Group, Mayne Pharma Group, Medical Developments International and Opthea.

How do I contact ECO Animal Health Group's investor relations team?

ECO Animal Health Group's physical mailing address is 78 Coombe Road, NEW MALDEN, KT3 4QS, United Kingdom. The company's listed phone number is +44-20-83362900. The official website for ECO Animal Health Group is www.ecoanimalhealthgroupplc.com.

LON:EAH - ECO Animal Health Group Stock Price Target and Predictions

Analyst Price Target for EAH

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of ECO Animal Health Group?

What is the current price target for ECO Animal Health Group?

What is the current consensus analyst rating for ECO Animal Health Group?

What other companies compete with ECO Animal Health Group?

How do I contact ECO Animal Health Group's investor relations team?